structure ccr5 chemokine receptor-hiv entry inhibitor maraviroc complex 
ccr5 chemokine receptor acts co-receptor hiv- viral entry report angstrom-resolution crystal structure human ccr5 bound marketed hiv drug maraviroc structure reveals ligand-binding site distinct proposed major recognition sites chemokines viral glycoprotein gp120 providing insights mechanism allosteric inhibition chemokine signaling viral entry comparison ccr5 cxcr4 crystal structures along models co-receptor-gp120-v3 complexes suggests different charge distributions steric hindrances caused residue substitutions may major determinants hiv- co-receptor selectivity high-resolution insights ccr5 can enable structure-based drug discovery treatment hiv- infection 
